Pharmaceutical exports surge by 30% in July 2024

Significant growth observed in both value and quantity of exports.

In the first quarter after deregulation, pharma sector revenue up by 25%

The increase in revenue is driven mostly by price increases as drug manufacturers can finally raise prices based on business need and rising costs instead of regulatory fiat

Ferozsons launches biologic to treat diabetes

Pharmaceutical company’s biotech subsidiary to launch the new product in one of Pakistan’s biggest therapeutic areas

Ferozsons subsidiary launches human insulin

Company says Ferulin, developed with the highest quality standards, will provide effective and affordable diabetes treatment to patients 

BF Biosciences plans to raise Rs 1.37 billion through IPO 

IPO will consist of 25 million ordinary shares with floor price of PKR 55 per share

Searle to sell its entire shareholding in Pakistani subsidiary  

Board approves sale of 90.61% stake to IJARA-led consortium

Citi Pharma enters into supply agreement with India’s Murli Krishna Pharma 

Murli Krishna Pharma will supply high-quality Active Pharmaceutical Ingredients (APIs) and products exclusively to Citi Pharma in Pakistan

CCP approves acquisition of two Japanese pharma products by Hilton Pharma

Proposed transaction entails the acquisition of Methycobal and Myonal including their trademarks

Sales tax hike to 18% expected to raise medicine prices

Sales tax is also imposed on diagnostic kits/equipment across various specialties, including cardiology, neurology, oncology, and urology 

Hoechst Pakistan to acquire products and trademarks from Sanofi affiliates

Board approves strategic acquisition to strengthen product portfolio and market position

Lucky Core seals deal for Pfizer’s Karachi plant, pharma products

Asset Purchase Agreements signed, acquisition includes products such as Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D, and Mycitracin. 

Searle Company to divest entire stake in Searle Pakistan Limited

Board approves disposal of 100% shareholding; negotiations for terms underway

Lucky Core Industries expands portfolio with Pfizer assets acquisition

Deal includes a manufacturing facility, certain pharma products and trademarks associated with said products

Citi Pharma, Hangzhou Newsea partner to boost local API manufacturing

With an expected annual turnover of Rs15,000m, the JV underscores a push towards reducing import dependence and enhancing local manufacturing infrastructure in Pakistan’s pharmaceutical industry

Saudi investors exit Pakistan’s largest pharmacy chain. What happened and why?

From its origins as part of the Servis Group to multiple changes in ownership since its inception in 2005, Servaid has undergone an eventful two decades in existence